We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+8.87%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$51.1B
AUM Growth
+$2.09B
(+4.3%)
Cap. Flow
-$1.46B
Cap. Flow
% of AUM
-2.85%
Top 10 Holdings %
Top 10 Hldgs %
22.51%
Holding
1,173
New
222
Increased
229
Reduced
441
Closed
163
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XEC
CIMAREX ENERGY CO
XEC
|
+$190M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$171M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$139M |
| 4 |
Textron
TXT
|
+$133M |
| 5 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$325M |
| 2 |
EOG Resources
EOG
|
+$245M |
| 3 |
Honeywell
HON
|
+$186M |
| 4 |
Merck
MRK
|
+$149M |
| 5 |
Kohl's
KSS
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.75% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 14.77% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Communication Services | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
226
DELISTED
Immunogen Inc
IMGN
| $46.1M | 0.09% |
7,000,000
+2,500,000
| +56% | +$17.4M |
|
227
Synopsys
SNPS
$75.1B
| $45.8M | 0.09% |
166,000
+11,000
| +7% | +$2.79M |
|
228
Trane Technologies
TT
$102B
| $45.8M | 0.09% |
248,546
-8,001
| -3% | -$1.43M |
|
229
Duke Energy
DUK
$96.9B
| $45.6M | 0.09% |
462,060
-234,100
| -34% | -$23.5M |
|
230
Centene
CNC
$31.5B
| $45.6M | 0.09% |
624,612
-15,200
| -2% | -$1.04M |
|
231
Marvell Technology
MRVL
$174B
| $45.5M | 0.09% |
780,261
-360,600
| -32% | -$17.6M |
|
232
DuPont de Nemours
DD
$19.1B
| $45.3M | 0.09% |
466,369
-11,074
| -2% | -$1.11M |
|
233
Sempra
SRE
$57.3B
| $45.3M | 0.09% |
683,770
-1,385,828
| -67% | -$94.8M |
|
234
OneMain Financial
OMF
$7.44B
| $45.1M | 0.09% |
752,027
-163,439
| -18% | -$9.25M |
|
235
Huntington Bancshares
HBAN
$35.1B
| $45M | 0.09% |
3,150,300
+2,065,807
| +190% | +$31.6M |
|
236
Electronic Arts
EA
$53B
| $44.7M | 0.09% |
311,051
-6,492
| -2% | -$921K |
|
237
DexCom
DXCM
$33B
| $44.5M | 0.09% |
417,100
+70,000
| +20% | +$6.72M |
|
238
American International
AIG
$41.8B
| $44.4M | 0.09% |
932,138
+133,917
| +17% | +$6.62M |
|
239
Prudential Financial
PRU
$42.7B
| $44.3M | 0.09% |
432,337
-20,300
| -4% | -$2.07M |
|
240
Crown Holdings
CCK
$13B
| $44.3M | 0.09% |
433,170
+19,893
| +5% | +$2.1M |
|
241
Baxter International
BAX
$14.5B
| $44.1M | 0.09% |
548,447
-374,455
| -41% | -$31.4M |
|
|
XLRN
242
DELISTED
Acceleron Pharma
XLRN
| $43.9M | 0.09% |
+350,000
| New | +$44.1M |
|
243
Patria Investments
PAX
$1.8B
| $43.9M | 0.09% |
2,490,351
-142,036
| -5% | -$2.27M |
|
244
PPG Industries
PPG
$25.3B
| $43.5M | 0.09% |
256,498
-1,200
| -0.5% | -$206K |
|
|
BNY
245
Bank of New York Mellon
BNY
$106B
| $43.2M | 0.08% |
843,916
+168,900
| +25% | +$8.45M |
|
246
Constellation Brands
STZ
$22.4B
| $42.9M | 0.08% |
183,367
-4,400
| -2% | -$1.03M |
|
247
Goodyear
GT
$2.02B
| $42.9M | 0.08% |
2,500,000
+1,000,000
| +67% | +$18.4M |
|
248
Syndax Pharmaceuticals
SNDX
$1.7B
| $42.8M | 0.08% |
2,491,272
+741,272
| +42% | +$13.6M |
|
249
Avantor
AVTR
$9.24B
| $42.6M | 0.08% |
1,200,000
| – | – |
|
250
Gilead Sciences
GILD
$163B
| $42.6M | 0.08% |
618,777
+556,200
| +889% | +$37.1M |
|
Similar funds
Adage Capital Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Adage Capital Partners held 1,173 positions worth $51.1B, up 4.3% from $49B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Adage Capital Partners's Q2 2021 filing shows 222 new, 229 increased, 441 reduced and 163 closed positions. Its largest new stake was Royal Dutch Shell PLC ADS Class A: 3,150,000 shares worth $127M. The largest sale was GW Pharmaceuticals Plc American Depositary Shares, an estimated $325M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q2 2021 buy was Royal Dutch Shell PLC ADS Class A: 3,150,000 shares worth $127M.
- Adage Capital Partners added most to CIMAREX ENERGY CO in Q2 2021, an estimated $190M increase.
- Adage Capital Partners's biggest Q2 2021 reduction was EOG Resources, cutting an estimated $245M.
- Adage Capital Partners fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $325M.
- Adage Capital Partners's ten largest holdings make up 23% of its $51.1B portfolio in Q2 2021.
- Adage Capital Partners opened 222 new positions and closed 163 in Q2 2021.
- Adage Capital Partners's portfolio value rose 4.3% quarter-over-quarter to $51.1B.
Based on Adage Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.